When early humans left Africa, they took only a small group of genes with them—this accidentally left behind many prostate cancer risk genes, making non-African populations less genetically prone to the disease.
Scientific Claim
The out-of-Africa population bottleneck significantly shaped global differences in prostate cancer genetic risk, with non-African populations showing lower risk due to loss of ancestral risk alleles during migration.
Original Statement
“These differences may be explained by the out-of-Africa bottleneck and natural selection... Large allele frequency differences can quickly arise via founder effects and population bottlenecks. The great reshuffling of allele frequencies that occurred during the out-of-Africa bottleneck may have contributed to health disparities and differences in CaP risk across populations.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study uses population genetic modeling and allele frequency comparisons to infer historical bottlenecks. It does not measure ancient DNA or simulate migration, so 'may be explained' is the correct verb strength.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Ancient DNA Cohort StudyLevel 2aWhether ancestral African populations had higher frequencies of prostate cancer risk alleles than early non-African migrants.
Whether ancestral African populations had higher frequencies of prostate cancer risk alleles than early non-African migrants.
What This Would Prove
Whether ancestral African populations had higher frequencies of prostate cancer risk alleles than early non-African migrants.
Ideal Study Design
Analysis of whole-genome sequences from 50 ancient human remains (10,000–50,000 years old) from sub-Saharan Africa, the Levant, and Europe, with targeted genotyping of the 68 prostate cancer risk SNPs to reconstruct allele frequency changes across the out-of-Africa migration.
Limitation: Limited sample size and DNA preservation; cannot capture full population diversity.
Prospective Cohort StudyLevel 2aWhether individuals with higher levels of African ancestry (indicating less bottleneck effect) have higher prostate cancer genetic risk scores.
Whether individuals with higher levels of African ancestry (indicating less bottleneck effect) have higher prostate cancer genetic risk scores.
What This Would Prove
Whether individuals with higher levels of African ancestry (indicating less bottleneck effect) have higher prostate cancer genetic risk scores.
Ideal Study Design
A cohort of 10,000 African Americans with detailed ancestry proportions (via ADMIXTURE) and genotyped for the 68 SNPs, testing whether GRS correlates with proportion of West African ancestry after adjusting for socioeconomic factors.
Limitation: Cannot isolate bottleneck effects from post-migration selection or admixture.
Systematic Review & Meta-AnalysisLevel 1aWhether the 68 prostate cancer risk SNPs show greater allele frequency divergence between African and non-African populations than expected under neutral drift alone.
Whether the 68 prostate cancer risk SNPs show greater allele frequency divergence between African and non-African populations than expected under neutral drift alone.
What This Would Prove
Whether the 68 prostate cancer risk SNPs show greater allele frequency divergence between African and non-African populations than expected under neutral drift alone.
Ideal Study Design
Meta-analysis of 30+ population genetic studies comparing FST and allele frequency distributions of the 68 prostate cancer SNPs versus 10,000 matched neutral SNPs across global populations.
Limitation: Cannot prove the bottleneck was the cause—other demographic events could explain divergence.
Experimental Population Bottleneck ModelLevel 4Whether artificially bottlenecking a genetically diverse animal population reduces frequency of disease-risk alleles over generations.
Whether artificially bottlenecking a genetically diverse animal population reduces frequency of disease-risk alleles over generations.
What This Would Prove
Whether artificially bottlenecking a genetically diverse animal population reduces frequency of disease-risk alleles over generations.
Ideal Study Design
A controlled experiment with 10 replicate populations of genetically diverse mice (n=500 each), randomly bottlenecked to 10 founders each, tracking frequency of 100 disease-risk alleles over 20 generations.
Limitation: Mice do not develop human prostate cancer; risk alleles are artificial proxies.
Computational Population SimulationLevel 5Whether simulated out-of-Africa bottlenecks reproduce the observed allele frequency patterns of the 68 prostate cancer SNPs.
Whether simulated out-of-Africa bottlenecks reproduce the observed allele frequency patterns of the 68 prostate cancer SNPs.
What This Would Prove
Whether simulated out-of-Africa bottlenecks reproduce the observed allele frequency patterns of the 68 prostate cancer SNPs.
Ideal Study Design
A computational simulation using realistic human demographic parameters (bottleneck size, timing, migration rates) to model allele frequency changes of the 68 SNPs over 60,000 years, comparing output to observed global frequencies.
Limitation: Depends entirely on model assumptions; cannot validate against real biological data.
Evidence from Studies
Supporting (1)
Genetic Hitchhiking and Population Bottlenecks Contribute to Prostate Cancer Disparities in Men of African Descent.
The study found that African men have higher prostate cancer risk because their ancestors kept more genetic risk factors, while people who left Africa lost some of those risk genes during their long journey — just like leaving some tools behind when moving houses.